Gu X, Jia C, Wang J. Advances in understanding the molecular mechanisms of neuronal polarity. Mol Neurobiol. 2023;60:2851–70.

Article  CAS  PubMed  Google Scholar 

Lafanechère L. The microtubule cytoskeleton: an old validated target for novel therapeutic drugs. Front Pharm. 2022;13:969183.

Article  Google Scholar 

Duly AMP, Kao FCL, Teo WS, Kavallaris M. βIII-tubulin gene regulation in health and disease. Front Cell Dev Biol. 2022;10:851542.

Article  PubMed  PubMed Central  Google Scholar 

Adrian M, Weber M, Tsai M-C, Glock C, Kahn OI, Phu L, et al. Polarized microtubule remodeling transforms the morphology of reactive microglia and drives cytokine release. Nat Commun. 2023;14:6322.

Article  ADS  CAS  PubMed  PubMed Central  Google Scholar 

Duan D, Lyu W, Chai P, Ma S, Wu K, Wu C, et al. Abl2 repairs microtubules and phase separates with tubulin to promote microtubule nucleation. Curr Biol. 2023;33:4582–98.

Article  CAS  PubMed  Google Scholar 

Munro EM. PAR proteins and the cytoskeleton: a marriage of equals. Curr Opin Cell Biol. 2006;18:86–94.

Article  CAS  PubMed  Google Scholar 

Drewes G, Ebneth A, Preuss U, Mandelkow E-M, Mandelkow E. MARK, a novel family of protein kinases that phosphorylate microtubule-associated proteins and trigger microtubule disruption. Cell. 1997;89:297–308.

Article  CAS  PubMed  Google Scholar 

Marx A, Nugoor C, Panneerselvam S, Mandelkow E. Structure and function of polarity-inducing kinase family MARK/Par-1 within the branch of AMPK/Snf1-related kinases. FASEB J. 2010;24:1637–48.

Article  CAS  PubMed  Google Scholar 

Biernat J, Wu YZ, Timm T, Zheng-Fischhofer Q, Mandelkow E, Meijer L, et al. Protein kinase MARK/PAR-1 is required for neurite outgrowth and establishment of neuronal polarity. Mol Biol Cell. 2002;13:4013–28.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Dejanovic B, Sheng M, Hanson JE. Targeting synapse function and loss for treatment of neurodegenerative diseases. Nat Rev Drug Discov. 2024;23:23–42.

Article  CAS  PubMed  Google Scholar 

Younas N, Saleem T, Younas A, Zerr I. Nuclear face of Tau: an inside player in neurodegeneration. Acta Neuropathol Commun. 2023;11:196.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chen YM, Wang QJ, Hu HS, Yu PC, Zhu J, Drewes G, et al. Microtubule affinity-regulating kinase 2 functions downstream of the PAR-3/PAR-6/atypical PKC complex in regulating hippocampal neuronal polarity. Proc Natl Acad Sci USA. 2006;103:8534–9.

Article  ADS  CAS  PubMed  PubMed Central  Google Scholar 

Gu GJ, Wu D, Lund H, Sunnemark D, Kvist AJ, Milner R, et al. Elevated MARK2-dependent phosphorylation of Tau in Alzheimer’s disease. J Alzheimer’s Dis. 2013;33:699–713.

Article  CAS  Google Scholar 

Zulfiqar B, Farooq A, Kanwal S, Asghar K. Immunotherapy and targeted therapy for lung cancer: current status and future perspectives. Front Pharm. 2022;13:1035171.

Article  CAS  Google Scholar 

Nguyen K, Hebert K, McConnell E, Cullen N, Cheng T, Awoyode S, et al. LKB1 signaling and patient survival outcomes in hepatocellular carcinoma. Pharm Res. 2023;192:106757.

Article  CAS  Google Scholar 

Fischer GM, Gliem TJ, Greipp PT, Rosenberg AE, Folpe AL, Hornick JL. Anaplastic kaposi sarcoma: a clinicopathologic and molecular genetic analysis. Mod Pathol. 2023;36:100191.

Article  PubMed  Google Scholar 

Zamperone A, Cohen D, Stein M, Viard C, Müsch A. Inhibition of polarity-regulating kinase PAR1b contributes to Helicobacter pylori inflicted DNA Double Strand Breaks in gastric cells. Cell Cycle (Georget, Tex). 2019;18:299–311.

Article  CAS  Google Scholar 

Sapir T, Sapoznik S, Levy T, Finkelshtein D, Shmueli A, Timm T, et al. Accurate balance of the polarity kinase MARK2/Par-1 is required for proper cortical neuronal migration. J Neurosci. 2008;28:5710–20.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Matenia D, Mandelkow EM. Emerging modes of PINK1 signaling: another task for MARK2. Front Mol Neurosci. 2014;7:37.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Xu L, Sun Z, Wei X, Tan H, Kong P, Li Z, et al. The inhibition of MARK2 suppresses cisplatin resistance of osteosarcoma stem cells by regulating DNA damage and repair. J Bone Oncol. 2020;23:100290.

Article  PubMed  PubMed Central  Google Scholar 

Wei X, Xu L, Jeddo SF, Li K, Li X, Li J. MARK2 enhances cisplatin resistance via PI3K/AKT/NF-κB signaling pathway in osteosarcoma cells. Am J Transl Res. 2020;12:1807–23.

CAS  PubMed  PubMed Central  Google Scholar 

Klutho PJ, Costanzo-Garvey DL, Lewis RE. Regulation of glucose homeostasis by KSR1 and MARK2. PLoS One. 2011;6:e29304.

Article  ADS  CAS  PubMed  PubMed Central  Google Scholar 

Pasapera AM, Heissler SM, Eto M, Nishimura Y, Fischer RS, Thiam HR, et al. MARK2 regulates directed cell migration through modulation of myosin II contractility and focal adhesion organization. Curr Biol. 2022;32:12–2718.e6.

Article  Google Scholar 

Mishra JP, Cohen D, Zamperone A, Nesic D, Muesch A, Stein M. CagA of Helicobacter pylori interacts with and inhibits the serine-threonine kinase PRK2. Cell Microbiol. 2015;17:1670–82.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lu H, Murata-Kamiya N, Saito Y, Hatakeyama M. Role of partitioning-defective 1/microtubule affinity-regulating kinases in the morphogenetic activity of Helicobacter pylori CagA. J Biol Chem. 2009;284:23024–36.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Imai S, Ooki T, Murata-Kamiya N, Komura D, Tahmina K, Wu W, et al. Helicobacter pylori CagA elicits BRCAness to induce genome instability that may underlie bacterial gastric carcinogenesis. Cell Host Microbe. 2021;29:941–58.

Article  CAS  PubMed  Google Scholar 

Manning G, Whyte DB, Martinez R, Hunter T, Sudarsanam S. The protein kinase complement of the human genome. Science. 2002;298:1912–34.

Article  ADS  CAS  PubMed  Google Scholar 

Courseaux A, Fernandes M, Grosgeorge J, Inglis J, Raynaud SD, Gaudray P. Human EMK1 is located on 11q12-q13, close to COX8 and FTH1. Mamm Genome. 1995;6:311–2.

Article  CAS  PubMed  Google Scholar 

Panneerselvam S, Marx A, Mandelkow EM, Mandelkow E. Structure of the catalytic and ubiquitin-associated domains of the protein kinase MARK/Par-1. Structure. 2006;14:173–83.

Article  CAS  PubMed  Google Scholar 

Yoshida H, Goedert M. Phosphorylation of microtubule-associated protein tau by AMPK-related kinases. J Neurochem. 2012;120:165–76.

Article  CAS  PubMed  Google Scholar 

Zhang S, Wang C, Lu J, Ma X, Liu Z, Li D, et al. In-Cell NMR Study of Tau and MARK2 Phosphorylated Tau. Int J Mol Sci. 2018;20:90

Article  PubMed  PubMed Central  Google Scholar 

McDonald JA. Canonical and noncanonical roles of Par-1/MARK kinases in cell migration. Int Rev Cell Mol Biol. 2014;312:169–99.

Article  PubMed  Google Scholar 

Timm T, Li X-Y, Biernat J, Jiao J, Mandelkow E, Vandekerckhove J, et al. MARKK, a Ste20-like kinase, activates the polarity-inducing kinase MARK/PAR-1. EMBO J. 2003;22:5090–101.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lizcano JM, Göransson O, Toth R, Deak M, Morrice NA, Boudeau J, et al. LKB1 is a master kinase that activates 13 kinases of the AMPK subfamily, including MARK/PAR-1. EMBO J. 2004;23:833–43.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Watkins JL, Lewandowski KT, Meek SEM, Storz P, Toker A, Piwnica-Worms H. Phosphorylation of the Par-1 polarity kinase by protein kinase D regulates 14-3-3 binding and membrane association. Proc Natl Acad Sci USA. 2008;105:18378–83.

Article  ADS  CAS  PubMed  PubMed Central  Google Scholar 

Deng S-S, Wu L-Y, Wang Y-C, Cao P-R, Xu L, Li Q-R, et al. Protein kinase A rescues microtubule affinity-regulating kinase 2-induced microtubule instability and neurite disruption by phosphorylating serine 409. J Biol Chem. 2015;290:3149–60.

Article  CAS